PlainRecalls
FDA Drug Low Class III Terminated

Duloxetine Delayed-Release Capsules, USP, 60 mg, 30-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, Manufactured for Apotex Corp. Weston Florida 33326, NDC 60505-2997-3; UPC # 360505299737;

Reported: July 20, 2016 Initiated: January 26, 2016 #D-1436-2016

Product Description

Duloxetine Delayed-Release Capsules, USP, 60 mg, 30-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, Manufactured for Apotex Corp. Weston Florida 33326, NDC 60505-2997-3; UPC # 360505299737;

Reason for Recall

Failed Dissolution Specification: Out of specification dissolution results when testing product stability.

Details

Recalling Firm
Apotex Scientific, Inc
Units Affected
605,989 (30 ct) bottles
Distribution
Nationwide, Alaska, Hawaii, and Puerto Rico.
Location
Arlington, TX

Frequently Asked Questions

What product was recalled?
Duloxetine Delayed-Release Capsules, USP, 60 mg, 30-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, Manufactured for Apotex Corp. Weston Florida 33326, NDC 60505-2997-3; UPC # 360505299737;. Recalled by Apotex Scientific, Inc. Units affected: 605,989 (30 ct) bottles.
Why was this product recalled?
Failed Dissolution Specification: Out of specification dissolution results when testing product stability.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 20, 2016. Severity: Low. Recall number: D-1436-2016.